In vitro activity of levofloxacin against recent gram-negative nosocomial pathogens

Chemotherapy

Volumn 51, Issue 1, 2005, Pages 44-50

  Lanzafame, Agata ^a   Bonfiglio, Giovanni ^b   Santini, Luca ^a   Mattina, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Fluoroquinolones; In vitro activity; Levofloxacin; Nosocomial pathogens

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; LEVOFLOXACIN; MEROPENEM; NETILMICIN; ANTIINFECTIVE AGENT; BETA LACTAM; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SAFETY; ENTEROBACTER CLOACAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA; CROSS INFECTION; DRUG EFFECT; GRAM NEGATIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN;

EID: 21344465157     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084418     Document Type: Article

References (16)

1. Frank U, Jonas D, Lupke T, et al: Antimicrobial susceptibility among nosocomial pathogens isolated in intensive care units in Germany. Eur J Clin Microbiol Infect Dis 2000;19:888-891.
2. Siegrist HH, Nepa MC, Jacquet A: Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: A multicentre study. J Antimicrob Chemother 1999;43(suppl C):51-54.
3. Nicoletti G, Bonfiglio G, Bartoloni A, et al: Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: A 2-year comparison. Int J Antimicrob Agents 2000;15:265-269.
4. Ferrara AM, Fietta AM: New developments in antibacterial choice for lower respiratory tract infections in elderly patients. Drugs Aging 2004;21:167-86.
5. National Committee for Clinical Laboratory Standards (NCCLS): Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, ed 5. NCCLS document M7-A5. Wayne, NCCLS, 2000.
6. National Committee for Clinical Laboratory Standards (NCCLS): Performance Standards for Antimicrobial Susceptibility Testing; 11th Informational Supplement. NCCLS document M100-S11. Wayne, NCCLS, 2001.
7. Bonfiglio G, Perilli MG, Stefani S, Amicosante G, Nicoletti G: Prevalence of extended spectrum β-lactamases among Enterobacteriaceae: An Italian survey. Int J Antimicrob Agents 2000;19:213-217.
8. Davis R, Bryson HM: Levofloxacin: A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy. Drugs 1994;47:677-700.
9. Hurst M, Lamb HM, Scott LJ, Figgitt DP: Levofloxacin: An updated review of its use in the treatment of bacterial infections. Drugs 2002;62:2127-2167.
10. Gesu GP, Marchetti F, Piccoli L, Cavallero A: Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian Laboratories. Antimicrob Agents Chemother 2003;47:816-819.
11. Segatore B, Setacci D, Perilli M, et al: Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1999;43:428-431.
12. Segatore B, Setacci D, Perilli M, Franceschini N, Marchetti F, Amicosante G: Bactericidal activity of levofloxacin and ciprofloxacin on clinical isolates of different phenotypes of Pseudomonas aeruginosa. Int J Antimicrob Agents 2000;13:223-226.
13. Bonfiglio G: Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa? Chemotherapy 2001;47:239-242.
14. Bonfiglio G, Cascone C, Azzarelli C, Cafiso V, Marchetti F, Stefani S: Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates. J Antimicrob Chemother 2000;45:115-117.
15. Di Bonaventura G, D'Antonio D, Catamo G, D'Ercole S, Piccolomini R: Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients. Chemotherapy 2002;48:134-137.
16. Acar JF, Goldstein FW: Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997;24(suppl 1):S67-S73.